// App-Quantinova.ai

81 : Prescribing NSAIDs/COX-2s in patients having osteoarthritis is associated with both negative clinical outcomes and higher costs

Researchers

Presenter

  • Stuart Silverman

Principal Investigators

  • Patricia Schepman

  • Alan G. White

  • Nguyen Le

  • Michael Somma

  • Craig G. Beck

  • Rebecca L. Robinson

  • J. Bradford Rice

Medical Centers

  • David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA

  • Pfizer Inc, New York, NY

  • Analysis Group, Inc., Boston, MA

  • Evidera, Inc., London, United Kingdom

  • Eli Lilly, Indianapolis, IN

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

Disease

  • Osteoarthritis

  • Nephrotoxicity

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved